Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AKBA compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
AKBA
Akebia Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
AKBA
Akebia Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
AKBA
with
LLY
Uncorrelated: r 0.14 · 499D.
No shared co-movers.
AKBA, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
AKBA
Akebia Therapeutics, Inc.
Change
0.39
▼
−7.97%
Mkt cap
$118.1M
Revenue
$37M
Q3 FY26
Revenue
$236M
FY25
LLY
ELI Lilly & Co
Change
1,364.05
▼
−0.05%
Regular session
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 6 '26
AKBA
Akebia Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
0.39
▼
−7.97%
Price
1,364.05
▼
−0.05%
$118.1M
Mkt cap
$1.2T
Q3 FY26
$37M
Revenue
$24.4B
Q3 FY26
FY25
$236M
Revenue
$65.2B
FY25
Change
Change
AKBA
0.39
▼
−7.97%
vs
LLY
1,364.05
▼
−0.05%
Regular session
Nov 6 '26